Anagenics Ltd: Completion of Face Medi Group Sale
Anagenics Ltd: Release of Shares from Voluntary Escrow
Anagenics Ltd: Restructuring Update
Anagenics Ltd: Appendix 4G and Corporate Governance Statement 2024
Anagenics Ltd: Market Update
Anagenics Ltd: Annual Report to shareholders
Anagenics Ltd: VOLUNTARY SUSPENSION UPDATE
Anagenics Ltd: Suspension from Official Quotation
Anagenics Ltd: Trading Halt
Anagenics Ltd: Pause in Trading
Anagenics Ltd: FY24 4E Presentation
Anagenics Ltd: Appendix 4E and Preliminary Final Report
Anagenics Ltd: Company Update License Partnership Announcement
Anagenics Ltd: Appendix 4C Cash Flow & Activities Report
Anagenics Ltd: Lapse of unlisted options
Anagenics Ltd: Change of Company Secretary
Anagenics Ltd: Midkine Antibody Licensing Deal
Anagenics Ltd: Trading Halt
Anagenics Ltd: Pause in Trading
Anagenics Ltd: Response to Appendix 3Y Query
No Data
No Data